Showing results (91-100 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|April 28, 2025
Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitorsMichael Sayer, Hirofumi Hamano, Misako Nagasaka, et al.Cardio-Oncology (London, England)|November 11, 2025
Association between cardiac radiation dose and coronary artery calcification progression in breast cancer patients after radiotherapy: the modifying role of concomitant systemic inflammation (BACCARAT study)Médéa Locquet, Georges Tarlet, David Broggio, et al.Cardio-Oncology (London, England)|October 23, 2025
Pathways in the brain, heart and lung influenced by SARS-CoV-2 NSP6 and SARS-CoV-2 regulated miRNAs: an in silico study hinting cancer incidenceShrabonti Chatterjee, Joydeep Mahata, Suneel Kateriya, et al.Cardio-Oncology (London, England)|October 1, 2025
The predictive value of coronary artery calcium deposit for cardiovascular events in patients treated with immune checkpoint inhibitorsMoaad Slieman, Ophir Freund, Galit Aviram, et al.Cardio-Oncology (London, England)|November 16, 2022
Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcomaJulius C Heemelaar, Jeroen Janson, Jerry Braun, et al.Cardio-Oncology (London, England)|February 10, 2026
Cardiovascular signaling proteins as predictors of the cardiac effects of doxorubicin treatment in children with acute lymphoblastic leukemiaSteven E Lipshultz, Holly M Smith, Stephen E Sallan, et al.Cardio-Oncology (London, England)|March 20, 2025
Dexrazoxane makes doxorubicin-induced heart failure a rare event in sarcoma patients receiving high cumulative dosesHaoyi Zheng, Huichun ZhanCardio-Oncology (London, England)|May 2, 2025
Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2bHui-Ming Chang, Jinn-Yuan Hsu, Chul Ahn, et al.Cardio-Oncology (London, England)|April 24, 2025
Long-term impact of anthracycline in early-stage breast cancer, bridging of MiRNAs profiler for early cardiotoxicityNattaya Poovorawan, Thiti Susiriwatananont, Chinachote Teerapakpinyo, et al.Cardio-Oncology (London, England)|June 17, 2023
Atrial fibrillation in cancer survivors - a systematic review and meta-analysisYueyang Bao, John Lee, Udit Thakur, et al.Pageof 45